tiprankstipranks
Fairchem Organics Ltd (IN:FAIRCHEMOR)
:FAIRCHEMOR
India Market

Fairchem Organics Ltd (FAIRCHEMOR) AI Stock Analysis

1 Followers

Top Page

IN:FAIRCHEMOR

Fairchem Organics Ltd

(FAIRCHEMOR)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
₹512.00
▼(-33.17% Downside)
Action:ReiteratedDate:03/24/26
The score is held back primarily by weakening financial performance (declining margins, falling revenue, and negative operating/free cash flow) and a clearly bearish technical trend (below major moving averages with negative MACD). Valuation adds only modest support due to a negative P/E and a small dividend yield.
Positive Factors
Strong balance sheet (high equity ratio)
A 75.2% equity ratio denotes low financial leverage and greater solvency, giving the company resilience to demand shocks and the flexibility to fund working capital or modest capex without urgent refinancing. This structural strength supports operations and strategic choices over the next 2-6 months.
Negative Factors
Declining revenue trends
A material top-line decline (-13.4% reported) signals weakening demand or lost volumes in core B2B channels. Sustained revenue contraction limits scale benefits, pressures per-unit fixed cost absorption, and undermines medium-term investment capacity needed to move up the value chain.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet (high equity ratio)
A 75.2% equity ratio denotes low financial leverage and greater solvency, giving the company resilience to demand shocks and the flexibility to fund working capital or modest capex without urgent refinancing. This structural strength supports operations and strategic choices over the next 2-6 months.
Read all positive factors

Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)

Fairchem Organics Ltd Business Overview & Revenue Model

Company Description
Fairchem Organics Limited manufactures and sells specialty oleo chemicals and intermediate nutraceuticals in India, East Asia, the Middle East, North America, and South America. It provides nutraceuticals comprising natural and mixed tocopherol an...
How the Company Makes Money
Fairchem Organics makes money primarily by selling specialty chemical products to business customers (B2B). Its core revenue stream is product sales from its portfolio of oleochemical derivatives and related specialty chemicals, where earnings are...

Fairchem Organics Ltd Financial Statement Overview

Summary
Financials indicate stress: profitability and revenue declined (gross margin 12.4%, net margin 4.1%, revenue -13.4%), and cash generation is weak with negative operating cash flow and free cash flow. A strong equity ratio (75.2%) supports stability, but rising leverage and lower ROE (7.3%) temper the outlook.
Income Statement
55
Neutral
Balance Sheet
70
Positive
Cash Flow
40
Negative
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue4.77B5.38B6.21B6.47B6.42B3.96B
Gross Profit702.48M666.52M1.54B1.56B1.78B1.25B
EBITDA228.90M441.21M681.10M729.68M1.05B688.05M
Net Income60.57M219.74M405.00M435.01M679.06M424.85M
Balance Sheet
Total Assets3.88B4.02B3.34B3.42B3.24B2.59B
Cash, Cash Equivalents and Short-Term Investments13.12M12.86M84.00K838.00K83.00K460.00K
Total Debt544.04M630.32M73.18M501.68M620.30M568.03M
Total Liabilities943.42M997.98M443.77M831.48M919.26M898.68M
Stockholders Equity2.94B3.02B2.90B2.59B2.32B1.69B
Cash Flow
Free Cash Flow198.36M-464.87M563.52M348.89M58.91M163.03M
Operating Cash Flow306.58M-203.78M744.80M496.15M404.85M394.26M
Investing Cash Flow-106.46M-255.71M-176.25M-144.92M-341.84M-228.02M
Financing Cash Flow-200.08M459.49M-568.55M-351.24M-63.19M-166.29M

Fairchem Organics Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price766.10
Price Trends
50DMA
564.58
Negative
100DMA
626.14
Negative
200DMA
729.76
Negative
Market Momentum
MACD
-16.26
Negative
RSI
50.34
Neutral
STOCH
86.50
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Neutral. The current price of 766.1 is above the 20-day moving average (MA) of 498.86, above the 50-day MA of 564.58, and above the 200-day MA of 729.76, indicating a neutral trend. The MACD of -16.26 indicates Negative momentum. The RSI at 50.34 is Neutral, neither overbought nor oversold. The STOCH value of 86.50 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:FAIRCHEMOR.

Fairchem Organics Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
₹8.78B33.580.26%-4.07%-12.36%
64
Neutral
₹7.72B19.710.38%13.01%32.44%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹9.61B3.950.82%-2.41%178.19%
60
Neutral
₹5.86B22.241.23%0.69%-7.54%
47
Neutral
₹7.35B52.5616.43%
46
Neutral
₹6.58B-2,425.331.07%-22.10%-85.56%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:FAIRCHEMOR
Fairchem Organics Ltd
522.20
-355.59
-40.51%
IN:AMNPLST
Amines & Plasticizers Ltd.
159.60
-55.02
-25.64%
IN:INDOAMIN
Indo Amines Limited
106.40
-17.62
-14.21%
IN:JAYAGROGN
Jayant Agro-Organics Limited
195.30
-30.83
-13.63%
IN:MANALIPETC
Manali Petrochemicals Limited
55.89
1.15
2.10%
IN:VALIANTORG
Valiant Organics Limited
262.30
-90.95
-25.75%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026